Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cesare R Sirtori

Showing results (1-10 of 134) with videos related to

Pageof 14
Sort By:
Pharmacological Research|March 25, 2014
The pharmacology of statinsCesare R Sirtori
Expert Opinion on Investigational Drugs|October 4, 2011
Investigational CETP antagonists for hyperlipidemia and atherosclerosis preventionCesare R Sirtori
Current Opinion in Investigational Drugs (London, England : 2000)|June 11, 2002
Use of recombinant apolipoproteins in vascular diseases: the case of apoA-IGiulia Chiesa, Cesare R Sirtori
Cardiovascular Therapeutics|May 20, 2008
Viability of developing CETP inhibitorsCesare R Sirtori, Giuliana Mombelli
Current Opinion in Lipidology|March 19, 2003
Apolipoprotein A-I(Milano): current perspectivesGiulia Chiesa, Cesare R Sirtori
Annals of Medicine|July 9, 2003
Recombinant apolipoprotein A-I(Milano): a novel agent for the induction of regression of atherosclerotic plaquesGiulia Chiesa, Cesare R Sirtori
Expert Opinion on Investigational Drugs|March 1, 2006
Therapeutic use of the high-density lipoprotein protein and peptidesMarta Marchesi, Cesare R Sirtori
Atherosclerosis|November 29, 2005
LDL-cholesterol lowering or HDL-cholesterol raising for cardiovascular prevention. A lesson from cholesterol turnover studies and othersCesare R Sirtori, Remo Fumagalli
Current Opinion in Cardiology|June 4, 2008
Acute effects of high-density lipoproteins: biochemical basis and clinical findingsGiulia Chiesa, Cinzia Parolini, Cesare R Sirtori
The British Journal of Nutrition|April 6, 2007
Hypocholesterolaemic effects of soya proteins: results of recent studies are predictable from the anderson meta-analysis dataCesare R Sirtori, Ivano Eberini, Anna Arnoldi
Pageof 14

Showing results (1-10 of 134) with videos related to

Sort By:
Pageof 14
Pharmacological Research|March 25, 2014
The pharmacology of statinsCesare R Sirtori
Expert Opinion on Investigational Drugs|October 4, 2011
Investigational CETP antagonists for hyperlipidemia and atherosclerosis preventionCesare R Sirtori
Current Opinion in Investigational Drugs (London, England : 2000)|June 11, 2002
Use of recombinant apolipoproteins in vascular diseases: the case of apoA-IGiulia Chiesa, Cesare R Sirtori
Cardiovascular Therapeutics|May 20, 2008
Viability of developing CETP inhibitorsCesare R Sirtori, Giuliana Mombelli
Current Opinion in Lipidology|March 19, 2003
Apolipoprotein A-I(Milano): current perspectivesGiulia Chiesa, Cesare R Sirtori
Annals of Medicine|July 9, 2003
Recombinant apolipoprotein A-I(Milano): a novel agent for the induction of regression of atherosclerotic plaquesGiulia Chiesa, Cesare R Sirtori
Expert Opinion on Investigational Drugs|March 1, 2006
Therapeutic use of the high-density lipoprotein protein and peptidesMarta Marchesi, Cesare R Sirtori
Atherosclerosis|November 29, 2005
LDL-cholesterol lowering or HDL-cholesterol raising for cardiovascular prevention. A lesson from cholesterol turnover studies and othersCesare R Sirtori, Remo Fumagalli
Current Opinion in Cardiology|June 4, 2008
Acute effects of high-density lipoproteins: biochemical basis and clinical findingsGiulia Chiesa, Cinzia Parolini, Cesare R Sirtori
The British Journal of Nutrition|April 6, 2007
Hypocholesterolaemic effects of soya proteins: results of recent studies are predictable from the anderson meta-analysis dataCesare R Sirtori, Ivano Eberini, Anna Arnoldi
Pageof 14